Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

The global tuberculosis (TB) and child health community has increasingly prioritized the
childhood TB epidemic. In 2013, the childhood TB subgroup developed and published the …

Viral hepatitis results in 1.4 million deaths annually. The World Health Organization (WHO)
set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain …

Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …

This section summarizes the approaches to country validation of elimination of viral hepatitis
as a public health problem. It provides practical guidance on implementation, including the …

Hepatocellular carcinoma (HCC) is one of the major causes of morbidity, mortality, and
healthcare expenditure in patients with chronic liver disease in India. The Indian National …

Importance A 2013 review for the US Preventive Services Task Force (USPSTF) of hepatitis
C virus (HCV) screening found interferon-based antiviral therapy associated with increased …

The long‐term effects of direct‐acting antiviral therapies (DAAs) for chronic hepatitis C
(CHC) remain uncertain. The objective of this systematic review and meta‐analysis was to …

Background Statin may confer anticancer effect. However, the association between statin
and risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) or …